Fierce Pharma June 29, 2022
Zoey Becker

How has the pharma industry weighed human rights during its marketing of COVID-19 drugs and vaccines? That’s what the Pharmaceutical Accountability Foundation (PAF) sought to answer, and the results might not be what the industry wants to hear.

For its Fair Pharma Scorecard project, PAF ranked 26 companies involved in selling COVID-19 drugs, vaccine and diagnostics based on their compliance with 19 human rights principles. Not one company complied with all the criteria, and most “still need to take big steps” to make their products accessible and affordable, PAF said.

In general, PAF noticed a weariness toward knowledge sharing, iffy transparency levels and differences between various products at the same companies. For example, Pfizer’s compliance with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Survey / Study, Trends
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals
Scientists reveal new method that could reduce waste from drug manufacturing

Share This Article